Compas BE, Davis GE, Forsythe CJ, Wagner BM Assessment of major and daily stressful events during adolescence: the Adolescent Perceived Events Scale. J Consult Clin Psychol. 1987 Aug;55(4):534-541. doi: 10.1037/0022-006X.55.4.534.
Due P, Damsgaard MT, Lund R, Holstein BE Is bullying equally harmful for rich and poor children?: a study of bullying and depression from age 15 to 27. Eur J Public Health. 2009 Oct;19(5):464-9. doi: 10.1093/eurpub/ckp099. Epub 2009 Jul 8.
Jansen DE, Veenstra R, Ormel J, Verhulst FC, Reijneveld SA Early risk factors for being a bully, victim, or bully/victim in late elementary and early secondary education. The longitudinal TRAILS study. BMC Public Health. 2011 Jun 6;11:440. doi: 10.1186/1471-2458-11-440.
Luukkonen AH, Räsänen P, Hakko H, Riala K; STUDY-70 Workgroup Bullying behavior in relation to psychiatric disorders and physical health among adolescents: a clinical cohort of 508 underage inpatient adolescents in Northern Finland. Psychiatry Res. 2010 Jun 30;178(1):166-70. doi: 10.1016/j.psychres.2010.04.022. Epub 2010 May 14.
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.